Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
ALTR Altair Engineering
- 110.230
- +0.190+0.17%
Close Jan 8 16:00 ET
9.40BMarket Cap275.58P/E (TTM)
110.390High110.000Low1.24MVolume110.000Open110.040Pre Close137.11MTurnover2.68%Turnover RatioLossP/E (Static)85.30MShares113.12052wk High11.23P/B5.12BFloat Cap75.71052wk Low--Dividend TTM46.43MShs Float113.120Historical High--Div YieldTTM0.35%Amplitude16.550Historical Low110.252Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Altair Engineering Stock Forum
$Altair Engineering (ALTR.US)$
• $Carvana (CVNA.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $Newmont (NEM.US)$ : Canaccord Upgrades to Buy from Hold - PT $66 (from $60)
• $NiSource (NI.US)$ : Edward Jones Upgrades to Buy from Hold
• $Schlumberger (SLB.US)$ : Benchmark Upgrades to Buy from Hold - PT $55
Downgrades
• $Agilysys (AGYS.US)$ : Craig-Hallum Downgrades to Hold from Buy
• $Cleveland-Cliffs (CLF.US)$ : GLJ Research Downgrades t...
• $Axsome Therapeutics (AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics (CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
• $AutoZone (AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy (CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision (EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care (FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab (GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
No comment yet